Compare Elevance Health Inc. Common Stock (ELV) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elevance Health Inc. Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Elevance Health Inc. Common Stock trades at $412.7 (market cap $86.95B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Elevance Health Inc. Common Stock is far larger — about 3.4× Royalty Pharma plc Class A Ordinary Shares's market cap, and Elevance Health Inc. Common Stock pays the higher dividend (1.72%). Which is the better fit depends on your goals.
| ELV | RPRX | |
|---|---|---|
Market Cap | $86.95B | $25.27B |
Volume | 782,706 | 3,671,183 |
Sector | Health | Health |
52-Week High | $426.79 | $63.96 |
52-Week Low | $280.74 | $35.44 |
Enterprise Value | $107.76B | $32.50B |
Dividend Yield | 1.72% | 1.66% |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
